Impact of Wearable Technology on Heart Failure Management.

IF 0.5 Q4 MEDICINE, RESEARCH & EXPERIMENTAL
Galen Medical Journal Pub Date : 2024-09-11 eCollection Date: 2024-01-01 DOI:10.31661/gmj.v13i.3469
Negar Jafari, Sahar Yousefi Ghalati, Venus Shahabi Raberi, Saba Moalemi, Arash Amin
{"title":"Impact of Wearable Technology on Heart Failure Management.","authors":"Negar Jafari, Sahar Yousefi Ghalati, Venus Shahabi Raberi, Saba Moalemi, Arash Amin","doi":"10.31661/gmj.v13i.3469","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Heart failure (HF) is a chronic and progressive condition that its management presents significant challenges in both clinical settings and patient self-care. Recent advances in wearable technology offer promising solutions to these challenges by enabling continuous monitoring, early detection of clinical deterioration, and personalized care. This review aims to critically evaluate the impact of wearable technology on HF management Materials and Methods: This narrative systematic review was conducted across multiple databases, including PubMed, Web of Science, and the Cochrane Library, to identify relevant studies published between 2010 and 2024. Studies on wearable devices for HF management and monitoring were included if they reported on clinical trials and provided data on integration into clinical workflows. Studies on other conditions or without original research data or Non-English papers were excluded.</p><p><strong>Results: </strong>Nine studies were evaluated in this study that were focusing on a variety of technologies ranging from consumer-grade fitness trackers to specialized bioimpedance sensors and wearable cardioverter-defibrillators. These studies demonstrate the potential of wearables to continuously monitor important health metrics, which can lead to early intervention and personalized care. However, there are still challenges to be addressed, including concerns about data accuracy, patient adherence, small sample sizes, and the incorporation of wearable data into clinical practice. While consumer devices are more accessible, their accuracy in a clinical setting is uncertain, while more advanced devices like the \"Volum\" monitor and BioZ sensors show promise but require further validation.</p><p><strong>Conclusion: </strong>This review highlights the growing importance of wearable technologies in HF management, actionable insights that can prevent disease progression. However, significant challenges remain, including the need for further validation, device optimization, and data standardization before routine clinical practice. Future advancements should focus on improving device accuracy, patient adherence, and data security, while ensuring equitable access to these technologies.</p>","PeriodicalId":44017,"journal":{"name":"Galen Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.5000,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11525106/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Galen Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31661/gmj.v13i.3469","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Heart failure (HF) is a chronic and progressive condition that its management presents significant challenges in both clinical settings and patient self-care. Recent advances in wearable technology offer promising solutions to these challenges by enabling continuous monitoring, early detection of clinical deterioration, and personalized care. This review aims to critically evaluate the impact of wearable technology on HF management Materials and Methods: This narrative systematic review was conducted across multiple databases, including PubMed, Web of Science, and the Cochrane Library, to identify relevant studies published between 2010 and 2024. Studies on wearable devices for HF management and monitoring were included if they reported on clinical trials and provided data on integration into clinical workflows. Studies on other conditions or without original research data or Non-English papers were excluded.

Results: Nine studies were evaluated in this study that were focusing on a variety of technologies ranging from consumer-grade fitness trackers to specialized bioimpedance sensors and wearable cardioverter-defibrillators. These studies demonstrate the potential of wearables to continuously monitor important health metrics, which can lead to early intervention and personalized care. However, there are still challenges to be addressed, including concerns about data accuracy, patient adherence, small sample sizes, and the incorporation of wearable data into clinical practice. While consumer devices are more accessible, their accuracy in a clinical setting is uncertain, while more advanced devices like the "Volum" monitor and BioZ sensors show promise but require further validation.

Conclusion: This review highlights the growing importance of wearable technologies in HF management, actionable insights that can prevent disease progression. However, significant challenges remain, including the need for further validation, device optimization, and data standardization before routine clinical practice. Future advancements should focus on improving device accuracy, patient adherence, and data security, while ensuring equitable access to these technologies.

可穿戴技术对心衰管理的影响
背景心力衰竭(HF)是一种慢性进展性疾病,其管理在临床环境和患者自我护理方面都面临着巨大挑战。可穿戴技术的最新进展为应对这些挑战提供了前景广阔的解决方案,可实现连续监测、临床恶化的早期检测和个性化护理。本综述旨在批判性地评估可穿戴技术对高血压管理的影响:我们在多个数据库(包括 PubMed、Web of Science 和 Cochrane Library)中进行了叙述性系统综述,以确定 2010 年至 2024 年间发表的相关研究。有关用于高血压管理和监测的可穿戴设备的研究,如果报告了临床试验并提供了与临床工作流程整合的数据,则被纳入其中。其他情况的研究、没有原始研究数据的研究或非英文论文均被排除在外:本研究评估了九项研究,这些研究关注的技术多种多样,从消费级健身追踪器到专用生物阻抗传感器和可穿戴式心律转复除颤器。这些研究表明,可穿戴设备具有持续监测重要健康指标的潜力,可以实现早期干预和个性化护理。然而,仍有一些挑战需要解决,包括数据准确性、患者依从性、样本量小以及将可穿戴设备数据纳入临床实践等问题。虽然消费类设备更容易获得,但它们在临床环境中的准确性还不确定,而更先进的设备,如 "Volum "监测器和BioZ传感器,虽然显示出前景,但还需要进一步验证:本综述强调了可穿戴技术在高血压管理中日益增长的重要性,以及可预防疾病进展的可操作见解。然而,在常规临床实践之前,仍存在重大挑战,包括需要进一步验证、设备优化和数据标准化。未来的进步应着眼于提高设备的准确性、患者的依从性和数据安全性,同时确保公平使用这些技术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Galen Medical Journal
Galen Medical Journal MEDICINE, RESEARCH & EXPERIMENTAL-
自引率
0.00%
发文量
13
期刊介绍: GMJ is open access, peer-reviewed journal in English and supported by Noncommunicable Diseases (NCD) Research Center of Fasa University of Medical Sciences that publishing by Salvia Medical Sciences Ltd. GMJ will consider all types of the following scientific papers for publication: - Editorial’s choice - Original Researches - Review articles - Case reports - Case series - Letter (to editors, to authors, etc) - Short communications - Medical Idea
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信